A phase II norovirus challenge study

Trial Profile

A phase II norovirus challenge study

Phase of Trial: Phase II

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs Norovirus Vaccine-Vaxart (Primary)
  • Indications Norovirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Nov 2017 New trial record
    • 30 Oct 2017 According to an Aviragen Therapeutics media release, this study is expected to begin in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top